#Herbalife#Nu Skin#Medifast#Q3 2026#direct selling#earnings

Diverging Q3 2026: Herbalife Extends Growth Streak as Nu Skin and Medifast Contract

Third-quarter 2026 results split the direct selling sector into two camps, with Herbalife posting its fifth consecutive quarter of year-over-year revenue growth while Nu Skin and Medifast reported double-digit declines. The contrast extends to full-year guidance, where one company raised its outlook and the others braced for further contraction.

AI-generated contentΒ·2 min read
Share:
Industry news β€” ElmΓ©lyΓΌlt, fΓ³kuszΓ‘lt munka
Industry news β€” ElmΓ©lyΓΌlt, fΓ³kuszΓ‘lt munka

Herbalife posts fifth straight quarter of growth

Herbalife reported net sales of $1.35 billion for the third quarter of 2026, up 6.0% year over year, or 7.6% in constant currency. The result marked the company's fifth consecutive quarter of year-over-year revenue growth.

North America, long a watch point for the sector, grew 1.7% in the quarter β€” the region's second consecutive quarter of expansion.

On the bottom line, Herbalife posted net income of $58.8 million, diluted earnings per share of $0.55 and adjusted EPS of $0.64. Adjusted EBITDA came in at approximately $182 million, with the margin widening to 13.5%.

For the full 2026 financial year, the company is reported to expect revenue growth of between 4.9% and 5.9%, an upward revision from its original expectations.

Nu Skin's core business under pressure as Rhyz expands

Nu Skin Enterprises reported third-quarter revenue of $311.0 million, a 14.6% decline from $364.2 million in 2025. The pressure was concentrated in the core business, where revenue fell roughly 19.2%.

The company's Rhyz manufacturing segment moved in the opposite direction, growing 19.3% to $56.8 million. The customer base, however, contracted 18% compared with the prior year.

Quarterly results showed a GAAP loss of $0.02 per share, with adjusted earnings of $0.10 per share, against a $0.34 profit a year earlier. For full-year 2026, Nu Skin expects revenue of $1.26–1.29 billion, equivalent to an annual decline of 13–15%.

Medifast: fewer coaches, higher revenue per coach

Medifast reported third-quarter revenue of $72.0 million, down 19.4% from $89.4 million in 2025, and a net loss of $17.5 million. Gross profit fell 19.5% to $50 million on lower sales volume.

The number of active, earning coaches dropped to 10,200 from 19,500 a year earlier. Revenue per active coach rose 54.1% year over year to $7,064, partly offsetting the decline in the field headcount.

Despite the year-over-year drop, Medifast's revenue has now stabilised around the $75 million mark for a fourth consecutive quarter. The company guides to full-year 2026 revenue of $280–300 million and a loss per share of $1.80–2.05.

A two-speed sector

The broader industry picture for the third quarter shows several large players, including USANA, continuing to report declining revenue, while Herbalife registered expansion.

Taken together, the quarter underlines a widening gap between companies that have returned to top-line growth and those still working through contracting customer and distributor bases.

Tags:#Herbalife#Nu Skin#Medifast#Q3 2026#direct selling#earnings

Related articles

Advertisement

[uk-house-ad] MLM System banner 728Γ—90

Free ebook Β· 33 pages

25 lessons you'll wish you'd known sooner

Mindset, recruiting, social selling, follow-up, leadership β€” five chapters, 25 practical principles. Such as: β€œDon’t chase the ones who don’t reply”, β€œAsk a question before you handle an objection”. Subscribe and the full ebook arrives in your first email.

Free, and yours straight away. Then two emails a week, unsubscribe in a click.

Unsubscribe anytime. No spam, ever.